Rare diseases
Investigational molecules
Locations
Via Michele Coppino 26, 12100 Cuneo, Italy
Azienda Ospedaliera Santa Croce E Carle in Cuneo, Italy specialises in clinical trials of conditions such as Plasma cell myeloma, Chronic lymphocytic leukaemia, Acute myeloid leukaemia, Follicular lymphoma, and other specialisations. This site conducts important research.
Clinical trials currently enrolling participants at this site.
Study of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)
ItalyRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
ItalyStudy of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma
ItalyLong-Term Study of Imeroprubart in Adults With Graves' Disease
ItalyStudy of IMVT-1402 Treatment for Adults with Graves' Disease
ItalyStudy of XELOX chemotherapy with or without dostarlimab after chemoradiation in patients with locally advanced rectal cancer
ItalyStudy comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients
ItalyStudy Comparing Olaparib and Chemotherapy for Patients with Recurrent Ovarian Cancer After Surgery
ItalyStudy of gemtuzumab ozogamicin with chemotherapy for adults aged 18-60 with newly diagnosed favorable-intermediate-risk acute myeloid leukemia
ItalyStudy of Atezolizumab, Carboplatin, and Nab-Paclitaxel for Patients with Metastatic Triple-Negative PD-L1 Positive Breast Cancer
ItalyStudy on Olaparib for Maintenance Therapy in Patients with Newly Diagnosed Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer
ItalyStudy on the Effectiveness and Safety of Fosmanogepix Compared to Caspofungin and Fluconazole for Adults with Candidemia or Invasive Candidiasis
ItalyGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
